Paying user area
Try for free
Medtronic PLC pages available for free this week:
- Analysis of Short-term (Operating) Activity Ratios
- DuPont Analysis: Disaggregation of ROE, ROA, and Net Profit Margin
- Analysis of Reportable Segments
- Common Stock Valuation Ratios
- Enterprise Value to EBITDA (EV/EBITDA)
- Capital Asset Pricing Model (CAPM)
- Operating Profit Margin since 2005
- Return on Assets (ROA) since 2005
- Analysis of Revenues
- Analysis of Debt
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Medtronic PLC for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Calculation
| P/OP | = | Share price1, 2, 3 | ÷ | Operating profit per share1 | Operating profit per share1 | = | Operating profit1 (in millions) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 18, 2026 | = | ÷ | = | ÷ | |||||||
| Jun 20, 2025 | = | ÷ | = | ÷ | |||||||
| Jun 20, 2024 | = | ÷ | = | ÷ | |||||||
| Jun 22, 2023 | = | ÷ | = | ÷ | |||||||
| Jun 23, 2022 | = | ÷ | = | ÷ | |||||||
| Jun 25, 2021 | = | ÷ | = | ÷ | |||||||
| Jun 19, 2020 | = | ÷ | = | ÷ | |||||||
| Jun 21, 2019 | = | ÷ | = | ÷ | |||||||
| Jun 22, 2018 | = | ÷ | = | ÷ | |||||||
| Jun 27, 2017 | = | ÷ | = | ÷ | |||||||
| Jun 28, 2016 | = | ÷ | = | ÷ | |||||||
| Jun 23, 2015 | = | ÷ | = | ÷ | |||||||
| Jun 20, 2014 | = | ÷ | = | ÷ | |||||||
| Jun 24, 2013 | = | ÷ | = | ÷ | |||||||
| Jun 26, 2012 | = | ÷ | = | ÷ | |||||||
| Jun 28, 2011 | = | ÷ | = | ÷ | |||||||
| Jun 29, 2010 | = | ÷ | = | ÷ | |||||||
| Jun 23, 2009 | = | ÷ | = | ÷ | |||||||
| Jun 24, 2008 | = | ÷ | = | ÷ | |||||||
| Jun 25, 2007 | = | ÷ | = | ÷ | |||||||
| Jun 28, 2006 | = | ÷ | = | ÷ | |||||||
| Jun 29, 2005 | = | ÷ | = | ÷ |
Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26), 10-K (reporting date: 2018-04-27), 10-K (reporting date: 2017-04-28), 10-K (reporting date: 2016-04-29), 10-K (reporting date: 2015-04-24), 10-K (reporting date: 2014-04-25), 10-K (reporting date: 2013-04-26), 10-K (reporting date: 2012-04-27), 10-K (reporting date: 2011-04-29), 10-K (reporting date: 2010-04-30), 10-K (reporting date: 2009-04-24), 10-K (reporting date: 2008-04-25), 10-K (reporting date: 2007-04-27), 10-K (reporting date: 2006-04-28), 10-K (reporting date: 2005-04-29).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Medtronic PLC Annual Report.
The financial trajectory between 2005 and 2026 reflects significant fluctuations in market valuation relative to operational earnings, characterized by a period of valuation expansion followed by a subsequent contraction.
- Share Price Dynamics
- The share price exhibited considerable volatility over the analyzed period. A notable decline occurred between 2005 and 2009, with the price dropping from 52.20 to 33.37. This was followed by a long-term growth phase that peaked in 2021 at 124.93. In the subsequent years, a corrective trend is observed, with the price stabilizing in the range of 79.34 to 86.34 between 2023 and 2026.
- Operating Profit per Share Trends
- Operating profit per share, with available data starting in 2013, shows a pattern of fluctuation and recovery. A significant low of 2.66 was recorded in 2015, followed by an increase to 4.92 by 2018. While the profit per share experienced a dip between 2019 and 2021, a steady upward trend is evident in the final years of the period, reaching a peak of 5.05 by 2026.
- Price to Operating Profit (P/OP) Analysis
- The P/OP ratio indicates a stark divergence between market pricing and operational performance during the mid-period. From a baseline of 11.80 in 2013, the ratio escalated to a peak of 37.44 in 2022, suggesting a period of aggressive valuation or diminished relative profitability. Following 2022, a consistent compression of the ratio is observed, trending downward to 15.70 by 2026. This contraction is driven by the combination of stabilizing share prices and increasing operating profit per share, indicating a shift toward a more grounded valuation.
Comparison to Competitors
| Medtronic PLC | Abbott Laboratories | Intuitive Surgical Inc. | UnitedHealth Group Inc. | |
|---|---|---|---|---|
| Jun 18, 2026 | ||||
| Jun 20, 2025 | ||||
| Jun 20, 2024 | ||||
| Jun 22, 2023 | ||||
| Jun 23, 2022 | ||||
| Jun 25, 2021 | ||||
| Jun 19, 2020 | ||||
| Jun 21, 2019 | ||||
| Jun 22, 2018 | ||||
| Jun 27, 2017 | ||||
| Jun 28, 2016 | ||||
| Jun 23, 2015 | ||||
| Jun 20, 2014 | ||||
| Jun 24, 2013 | ||||
| Jun 26, 2012 | ||||
| Jun 28, 2011 | ||||
| Jun 29, 2010 | ||||
| Jun 23, 2009 | ||||
| Jun 24, 2008 | ||||
| Jun 25, 2007 | ||||
| Jun 28, 2006 | ||||
| Jun 29, 2005 |
Based on: 10-K (reporting date: 2026-04-24), 10-K (reporting date: 2025-04-25), 10-K (reporting date: 2024-04-26), 10-K (reporting date: 2023-04-28), 10-K (reporting date: 2022-04-29), 10-K (reporting date: 2021-04-30), 10-K (reporting date: 2020-04-24), 10-K (reporting date: 2019-04-26), 10-K (reporting date: 2018-04-27), 10-K (reporting date: 2017-04-28), 10-K (reporting date: 2016-04-29), 10-K (reporting date: 2015-04-24), 10-K (reporting date: 2014-04-25), 10-K (reporting date: 2013-04-26), 10-K (reporting date: 2012-04-27), 10-K (reporting date: 2011-04-29), 10-K (reporting date: 2010-04-30), 10-K (reporting date: 2009-04-24), 10-K (reporting date: 2008-04-25), 10-K (reporting date: 2007-04-27), 10-K (reporting date: 2006-04-28), 10-K (reporting date: 2005-04-29).